CVS to split drugstore and insurance businesses; shares fall 10%
CVS Health announced a breakup of its $117 billion business, separating pharmacies from insurance and unwinding its $78 billion Aetna deal, as its stock dropped.
By BBCorp
What happened
CVS Health said it plans to split into two companies, separating its drugstore and pharmacy operations from its health insurance arm. Reports put the scale of the business being broken up at $117 billion and note the move reverses the company's $78 billion acquisition of Aetna, dismantling the vertically integrated healthcare group it built around that deal.
The decision came as a surprise to analysts covering the company, according to coverage of the announcement. CVS shares fell 10% following the news.
Why it matters
Large-cap breakups and spin-offs change how a company is valued, because separate units are priced on their own growth and margin profiles rather than as one group. When the company is a major index constituent, a sharp single-stock move can be felt in broad US equity benchmarks and in healthcare sector baskets, and it often prompts repositioning by funds that track those indices.
Surprise corporate restructuring also tends to lift volatility expectations around the sector, which can spill into wider risk sentiment. Shifts in equity risk appetite are one of the channels through which the dollar, and assets such as gold and crypto that trade alongside risk sentiment, can see knock-on flows.
What to watch
The articles point to further detail on how the separation would be structured and to analyst reaction, which was caught off guard by the decision, as the next things to follow.
US stocks